Avet-Loiseau, H., Ludwig, H., Landgren, O., Paiva, B., Morris, C., Yang, H., . . . Mateos, M. (2019). Minimal Residual Disease Status as a Surrogate Endpoint for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis. Clin Lymphoma Myeloma Leuk.
Citação norma ChicagoAvet-Loiseau, Hervé, Heinz Ludwig, Ola Landgren, Bruno Paiva, Chris Morris, Hui Yang, Kefei Zhou, Sunhee Ro, and Maria-Victoria Mateos. "Minimal Residual Disease Status As a Surrogate Endpoint for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis." Clin Lymphoma Myeloma Leuk 2019.
MLA citiranjeAvet-Loiseau, Hervé, et al. "Minimal Residual Disease Status As a Surrogate Endpoint for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis." Clin Lymphoma Myeloma Leuk 2019.